Medetomidine Production Cost Reports

The report provides a detailed analysis essential for establishing a Medetomidine manufacturing plant. It encompasses all critical aspects necessary for Medetomidine production, including the cost of Medetomidine production, Medetomidine plant cost, Medetomidine production costs, and the overall Medetomidine manufacturing plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Medetomidine production plant. These encompass manufacturing processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Medetomidine is a synthetic compound known for its analgesic and sedating properties. The compound is widely used as an anesthetic agent in animals, such as dogs and cats, to induce sedation during surgeries, which reduces stress in animals and facilitates the surgical procedure. Additionally, it is also used as a sedative in dogs over 12 weeks of age to support clinical procedures, medical examinations, and other minor surgical procedures.

The market for Medetomidine is primarily driven as an analgesic and anesthetic agent during surgical procedures in animals, which significantly contributes to its growing demand. Due to its potential analgesic properties, it is used during animal handling and treatment practices, which makes it a sought-after commodity among the animal welfare and veterinary medicine industries. Additionally, several factors, such as the availability of raw materials (2,3-dimethylbenzoyl chloride, etc.), pricing, its applications in veterinary medicine, employment in animal surgeries, scientific advancements, and quality standards, significantly influence industrial Medetomidine procurement globally.

Raw Material for Medetomidine Production

According to the Medetomidine manufacturing plant project report, the major raw materials for Medetomidine production include 2,3-dimethylbenzoyl chloride and 1-N,N-dimethyl sulfonyl-2-(tert-butyldimethylsily)-5-(2,3-dimethyl benzoyl) imidazole.

Manufacturing Process of Medetomidine

The extensive Medetomidine production cost report consists of the following industrial manufacturing process:

1. Production via Chemical Synthesis: This method of production is initiated by the reaction of 2,3-dimethylbenzoyl chloride and 1-N,N-dimethyl sulfonyl-2-(tert-butyldimethylsily)-5-(2,3-dimethyl benzoyl) imidazole in the presence of hydrochloric acid, which results in the formation of 4(5)-(2,3-dimethyl benzoyl) imidazole as an intermediate. Further, the obtained compound undergoes reduction by using monomethylamine to obtain medetomidine as the final product.

Medetomidine belongs to the class of imidazoles. The compound mainly serves as a surgical anesthetic agent in veterinary medicine. The IUPAC name of the compound is 5-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole. It is generally available in its hydrochloride salt form, medetomidine hydrochloride. Moreover, its molecular formula is C13H16N2, and its molecular weight is 200.28 g/mol. The density of the compound is 1.053 g/cm3, and it does not dissolve in water but is soluble in DMSO. The compound is a potent non-narcotic α2-adrenoreceptor agonist, which lead to sedation and is generally administered intravenously. The compound is stored at room temperature and sealed in a dry place.